Equitable Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$762K Buy
8,314
+330
+4% +$28.9K 0.03% 270
2026
Q1
$680K Buy
+7,984
New +$712K 0.03% 275
2025
Q3
Sell
-2,323
Closed -$211K 443
2025
Q2
$211K Sell
2,323
-11
-0.5% -$1K 0.01% 424
2025
Q1
$219K Hold
2,334
0.01% 446
2024
Q4
$212K Buy
+2,334
New +$223K 0.01% 456

Other funds holding CL

Equitable Trust's CL Position: Q2 2026 in Review

Equitable Trust increased its Colgate-Palmolive (CL) stake by 4.1% in Q2 2026, buying an estimated $28.9K and bringing the position to 8,314 shares worth $762K. The position accounts for 0.03% of the portfolio, ranked #270.

Equitable Trust first reported a position in CL in Q4 2024 and has held it in 5 quarters since. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Equitable Trust held 8,314 shares of Colgate-Palmolive worth $762K as of Q2 2026.
  • Equitable Trust bought 330 Colgate-Palmolive shares in Q2 2026, an estimated $28.9K.
  • Colgate-Palmolive made up 0.03% of Equitable Trust's portfolio in Q2 2026, its #270 holding.
  • Equitable Trust first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 5 quarters since.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.